DUBLIN--(BUSINESS WIRE)--The "Global Genetic Testing Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The global genetic testing market was valued at US$5.060 billion in 2018 and is projected to expand at a CAGR of 12.94% over the forecast period to reach US$9.296 billion by 2023.
Genetic tests are majorly conducted for diagnosing genetic disorders, identifying the mutation in the gene, and designing the treatment package. The growing prevalence of genetic disorders has been instrumental in driving the market.
Moreover, the reduction in the genetic testing prices has increased the number of individuals undergoing genetic testing since it has a scope beyond the medical field because of its ability to provide the ancestral history about an individual. However, concerns regarding the confidentiality and misleading advice along with the difficulty in interpreting the result has limited the market growth.
The global genetic testing market is competitive owing to the presence of well diversified international and regional players. The competitive landscape details strategies, products, and investments being done by key players in different technologies and companies to boost their market presence.
Major industry players profiled as part of the report are Abbot, Precipio Inc., Ariosa Diagnostics Inc., and Sequenom Inc.
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Global Genetic Testing Market By Type
6. Global Genetic Testing Market By Disease
7. Global Genetic Testing Market By Technology
8. Global Genetic Testing Market By Geography
9. Competitive Intelligence
10. Company Profiles
- F.Hoffmann-La Roche Ltd
- Precipio Inc.
- Ariosa Diagnostics, Inc.
- Luminex Corporation
- Sequenom, Inc.
- Illumina, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/7z4rzh/global_genetic?w=4